Thrombate III is the only antithrombin concentrate approved in both adult and pediatric patients for hereditary antithrombin deficiency. The Food and Drug Administration (FDA) has expanded the ...
Antithrombin deficiency, whether inherited or acquired, poses a significant risk factor for venous thromboembolism (VTE) by impairing the natural regulation of coagulation. As a critical plasma ...
ATryn Available for Patients with Hereditary Antithrombin Deficiency, a Rare Blood Clotting Disorder
DEERFIELD, Ill.--(BUSINESS WIRE)--Lundbeck Inc., a wholly owned subsidiary of H. Lundbeck A/S in Denmark (LUN: Copenhagen Stock Exchange), announced today that ATryn ® (Antithrombin [Recombinant]) is ...
A "genetic thrombophilia," or an inherited predisposition to develop blood clots, affects both you and your family. Genetic changes (also called mutations) in clotting factors, like factor V and ...
INNOVANCE Antithrombin assay is a cutting-edge, ready-to-use chromogenic reagent for the automated determination of antithrombin (AT) activity. It is highly accurate even at low activity levels and ...
– Company Remains on Track to File Investigational New Drug Application in Mid-2013 and to Initiate Phase I in Late 2013 – "Hemophilia and other rare bleeding disorders are characterized by ...
Hemophilia is an X-linked bleeding disorder resulting from a deficiency of coagulation factor VIII or IX (causing hemophilia A or B, respectively) and is characterized by spontaneous and traumatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results